ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO0147

Metabolic Imaging Differentiates Ischemia-Reperfusion Injury Severity in a Translational Mouse Model

Session Information

  • AKI: Mechanisms - 2
    November 07, 2025 | Location: Exhibit Hall, Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Acute Kidney Injury

  • 103 AKI: Mechanisms

Authors

  • Zavriyev, Alexander I, University of Pennsylvania, Philadelphia, Pennsylvania, United States
  • Adebesin, Bukola Y, University of Pennsylvania, Philadelphia, Pennsylvania, United States
  • Nguyen, John, University of Pennsylvania, Philadelphia, Pennsylvania, United States
  • Boehmler, Daniel, University of Pennsylvania, Philadelphia, Pennsylvania, United States
  • Sheehan, Molly Marie, University of Pennsylvania, Philadelphia, Pennsylvania, United States
  • Wang, Zhonglin, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
  • Yu, Jiangsheng, University of Pennsylvania, Philadelphia, Pennsylvania, United States
  • Islam, Ariful, University of Pennsylvania, Philadelphia, Pennsylvania, United States
  • Ge, Guanghui, University of Pennsylvania, Philadelphia, Pennsylvania, United States
  • Hartung, Erum Aftab, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
  • Levine, Matthew H., University of Pennsylvania, Philadelphia, Pennsylvania, United States
  • Kadlecek, Stephen, University of Pennsylvania, Philadelphia, Pennsylvania, United States
  • Gade, Terence P., University of Pennsylvania, Philadelphia, Pennsylvania, United States
Background

Renal ischemia–reperfusion injury (IRI) commonly complicates transplantation, surgery, and sepsis, leading to significant morbidity and mortality. Despite this clinical burden, diagnosis still relies on biopsy, underscoring the need for noninvasive biomarkers to inform prognosis. Here, we employ hyperpolarized (HP) 1-13C pyruvate to assess how IRI severity alters renal metabolism and perfusion in a translational model.

Methods

Wild-type C57BL/6 mice underwent moderate (28 min) or severe (45 min) IRI. HP 1-13C pyruvate (80mM) was injected (6.7mL/kg) via central line over 10s. Coronal EPSI images were acquired on a 7T scanner from 5s post-injection, every 3.5s (2×2 mm resolution, 7mm slice). Select kidneys were flash frozen 45s after injection and imaged by DESI mass spectrometry.

Results

Figure 1 shows KPL in IRI and contralateral (C/L) kidneys. On day 7, severe IRI kidneys had significantly lower KPL than moderate IRI (p<0.05). Moderate IRI also exhibited a significant KPL increase at day 7 versus 2h and day 1. In severe IRI, KPL peaked at 2h and declined thereafter. DESI MSI revealed decreasing m+1 lactate over time, with the highest level at 2h in severe IRI.

Conclusion

These findings invert the expected severity–pyruvate flux relationship: day-7 KPL is lower in severe IRI than in moderate IRI. Also, the correlation between KPL and DESI lactate in severe IRI—which is not present in moderate IRI—likely reflects the dynamic HP signal versus a static DESI snapshot. The impaired filtration expected in severe IRI may trap lactate, enhancing modality agreement, whereas faster clearance in moderate IRI decouples the measures. Importantly, both methods show that the C/L kidney’s metabolism shifts in parallel with the injured kidney, challenging the assumption that it behaves as a control.

Figure 1: Measured KPL values the IRI and C/L kidneys across groups, with corresponding DESI heatmaps of m+1 lactate below.

Funding

  • NIDDK Support

Digital Object Identifier (DOI)